SHMT2 and cancer: Ye et al. [34] described that in MYC amplified cancer cell lines and neuroblastoma patient samples, SHMT2 gets induced to produce NADPH (by initiating the degradation of serine to CO2) and to maintain redox balance under hypoxic conditions.